Abstract:Lipid nanoparticles (LNPs) have emerged as a versatile platform for mRNA delivery across a range of applications, including disease prevention, cancer immunotherapy, and gene editing. Structural models of mRNA-containing lipid nanoparticles (mRNA-LNPs) have also been proposed based on characterization of samples by using various advanced techniques. Among these, small angle neutron scattering (SANS) has proven essential for elucidating the lipid distribution within mRNA-LNPs, a factor crucial to both their preparation and efficacy. However, recent findings suggest that the mRNA-LNP samples prepared via commercial microfluidic techniques may contain a substantial fraction of drug-free LNPs, casting doubt on the validity of earlier structural models. In this study, we employed contrast variation SANS to characterize both drug-free LNPs and our mRNA-LNP sample, and quantified the proportion of drug-free LNPs present to be ~30% in our mRNA-LNP sample using nano flow cytometry. By removing the contributions of drug-free LNPs from the SANS data of our mRNA-LNP sample, we were able to precisely characterize the structure of mRNA-LNPs. Consequently, we proposed structural models for both drug-free LNPs and mRNA-LNPs. Notably, our analysis revealed similar lipid distributions and shell thicknesses between the two particle types, while the solvent content in mRNA-LNPs was significantly higher, leading to a larger core size. This work not only offers a method for accurately characterizing the structure of mRNA-LNPs, but also establishes criteria for selecting appropriate analytical techniques based on the structural parameters of interest. Therefore, our findings hold significant implications for the mechanistic understanding and quality control of mRNA-based vaccines.

Coacervation drives morphological diversity of mRNA encapsulating nanoparticles

Stereocomplex-Driven Morphological Transition of Coil-Rod-Coil Poly(lactic Acid)-Based Cylindrical Nanoparticles

Coarse-Grained Simulation of mRNA-Loaded Lipid Nanoparticle Self-Assembly

Molecular Dynamics Simulation of Lipid Nanoparticles Encapsulating mRNA

pH-dependent structural transitions in cationic ionizable lipid mesophases are critical for lipid nanoparticle function

Unraveling mechanisms of protein encapsulation and release in coacervates via molecular dynamics and machine learning

Evolution of the structure of lipid nanoparticles for nucleic acid delivery: From in situ studies of formulation to colloidal stability

Inverse Cubic and Hexagonal Mesophase Evolution within Ionizable Lipid Nanoparticles Correlates with mRNA Transfection in Macrophages

Coacervation for biomedical applications: innovations involving nucleic acids

Structural Characterization of mRNA Lipid Nanoparticles in the Presence of Intrinsic Drug-free Lipid Nanoparticles

Co-Delivery of mRNA and pDNA Using Thermally Stabilized Coacervate-Based Core-Shell Nanosystems

A Biopharmaceutical Perspective on Higher-Order Structure and Thermal Stability of mRNA Vaccines

Mesoscopic Structure of Lipid Nanoparticle Formulations for mRNA Drug Delivery: Comirnaty and Drug-Free Dispersions

Encapsulation state of messenger RNA inside lipid nanoparticles

Mechanistic Modeling of Lipid Nanoparticle Formation for the Delivery of Nucleic Acid Therapeutics

Structure and Dynamics of Hybrid Colloid-Polyelectrolyte Coacervates: Insights from Molecular Simulations

Lipid shape and packing are key for optimal design of pH-sensitive mRNA lipid nanoparticles

Entropy-Driven Pattern Formation Of Hybrid Vesicular Assemblies Made From Molecular And Nanoparticle Amphiphiles

Simulating Copolymeric Nanoparticle Assembly in the Co-solvent Method: How Mixing Rates Control Final Particle Sizes and Morphologies

A cationic lipid with advanced membrane fusion performance for pDNA and mRNA delivery

Revealing a Correlation between Structure and in vitro Activity of mRNA Lipid Nanoparticles